Intellectual Property
Minneapolis/St. Paul
How Should IP be Considered for Growth?
Trademarks and Brand Value
Process for Registering a Trademark in the United States
Post-Grant Options and Grounds of Challenge
What is a BioSimilar?
Marking a Product
Standard for Getting a Patent
What Doesn't a Patent Provide?
Patent Ownership and Patent Profile Analytics
Covered Business Method Review
First Item on IP To-Do List
How Does the Knowledge Gap Worsen Over Time?
Sponsor
Specimen
Merely Descriptive Refusal
Provisional Patent
Purposes of a Trademark
Technical Background
Demonstrating BioSimilarity Under U.S. Law
How Big Should My First Patent Be?
Seeking Money from Investors
Approvals of BioSimilars in Europe
Licensing Density
Proper Way to Use a Trademark
Merrifield Synthesis
How is Open Source Software Enforced?
How Much Does it Cost to Get a Patent?
Background
First Step in Performing a Patent Portfolio Audit
Most Common Client Question
Independent Claim vs Dependent Claim
A Less Expensive Alternative
Factors That Cause a Patent to Decline in Value
Different Parts of a Patent Document
How to Navigate BioSimilar Challenges
The Five Components of an Open Source Software Policy
Why Perform Risk Profile?
Open Source Initiative
Outside of Law
Inventorship
Traditional Re-Examination
Convergence Density
Two Main Value Drivers
By the Numbers Overview
Rewards of the Practice
Practicing an Invention
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Importance of Post-Grant Proceedings
Interpretational Differences Between Prosecution and Litigation
PTAB Timing Trial Dynamics
Do Narrow Patents Add Value to a Portfolio?
Forms of Confidential Information
Categories of Marks
Signing an NDA
What is a BioSimilar Product Under US Law?
Equal Value Patents
Circle "R"
"Claims" of a Patent
Post-Grant Review
5 Year View Point
Effective Stay Strategy
Trademark Filing Considerations
When to Do a Freedom to Operate
When is a House like a Patent?
Qualifying for a Patent
Freedom to Operate
Evaluation Agreement and Computer Codes
What is Prior Art?
"Who" - Audit Action Sheet
Raising Good Prosecution Visibility
Value-Driven Patent Portfolio
Joint Ventures and Dispute Resolution
Limited Valuable Patents in Technology Area
How to Remedy Unwanted Disclosure of Confidential Information
Copyright
Impact of US Hatch Waxman Act 1984
Forward Citation Landscape
Post-Grant Options and Cost
Researching Competitors' IP
"Whats" - Audit Action Sheet
Trade Dress
Improperly Marked Product
4 Ways to Prepare your Patent Portfolio for Battle.
Joint Venture Ground Rules
Cost of Registering a Trademark
Risks of Not Patenting
Patent Trial and Appeal Board
What Should a Company Patent?
Cited Art Landscape
Pre-Litigation Challenges
Freedom To Operate
Tracking Work History
NDAs and Computer Codes
Should IP be Part of Our Business Plan?
Patent Owner Rights
Freedom To Operate vs Clearance
Reasons to Consider Joint Ventures
Trade Secrets
What Makes Schwegman, Lundberg & Woessner Different?
Audit Action Sheet
Picking a Trademark
Hard Assets
Meet Mark Stignani
Post-Grant Proceedings and Patent Enforcement
Post-Grant Options and Estoppel
Biologics Price Competition and Innovation Act
FDA Guidelines for Demonstrating Biosimilarity
Challenges When Dealing with Patent Matters
How is Open Source Incorporated into Software?
Experience
Am I Required to Search for Prior Art?
How Does the Knowledge Gap Develop?
Patent Strategy Considerations
What Engineers Can Learn from Patent Profile Analytics
High Risk Joint Ventures
Moderate Risk Joint Ventures
Patent Status Updates
How Long Does an FTO Take?
Genericide
Patents and Other Forms of Intellectual Property Protection
Backward Citations
Patent Infringement
Freedom to Operate (FTO) Process
PTAB Final Argument Trial Dynamics
Confidential Information
What IP Should I Spend Money on First?
Trade Name Protection and Trademark Protection
Why Do You Enjoy Being a Lawyer?
Trademark
Third Party Confidentiality
Get Your Assignments Straight - Contribution of Owners
Prior Art Challenge
"Whens" - Audit Action Sheet
Hiring Patent Council
Engineers Not Understanding Patents
What Should a Company Understand at the End of an IP Audit?
Unlicensed Source Codes
Patents and Practicing an Invention
Common Law Trademark Rights
Calculating New Investments
How is the Entire Patent Considered Prior Art?
Cost/Value Curve of a High Level Patent
Attorneys and Patent Profile Analytics
Secondary Meaning of a Trademark
Auction Audit Sheet - Key Issues to Address
Inventorship vs Ownership
"Wheres" - Audit Action Sheet
How do Patent Prosecution Services Vary in Value?
Establishing Confidentiality
Portfolio Mapping
Naming Problems with BioSimilars
Downside of Static Budget Allocation for Patents
Patent Profile Analytics and Researchers
Litigation and BioSimilar Patenting
Consequences of Disclosing Confidential Information
Meet David Black
Are BioSimilars Being Approved in the US?
Date of First Use
Mitigating Risks of Past Damages
Non-Disclosure Agreement
BioSimilar Patenting Litigation Involving Large Amounts of Money
Why Should Claims Not Be Read on the Prior Art?
Patent Examination Process
Value Management Lifecycle
Renewing a Trademark Registration
Cost/Value Curve of Patent a Portfolio
Managing OSS
Important Attributes to Being a Successful Patent Lawyer
How Should IP be Considered for Acquisition?
Who Determines Substitution Factors?
Picking a Domain Name
Joint Venture Pitfalls
What to Do When First Selecting a Mark
Why Are Biologicals so Important?
Joint Venture and Financial Agreements
What Does an Audit Action Sheet Look Like?
Attorneys Not Understanding the Market
Budgeting for Drafting and Prosecution
Prior Art and Rejections
Using Product Association with IP Assets
Patent Citation Ranking
"How Much" - Audit Action Sheet
Benefits of Audit Action Sheet
Preventing "Genericide"
Provisional vs Non-Provisional Patent
How to Fix the Knowledge Gap
Claim Maps and BioSimilars
Litigation Density
Refused Trademark Recourse
"SM" Symbol
Domain Registration Considerations
Value Management and Cash Flow
What is a Patent?
Open Source Software
Impact of PTAB
Golden Rule of Auditing a Patent Portfolio
A Better Way to Allocate Patent Application Budgets
How is Schwegman Lundberg & Woessner Different?
Requirements to Receive a Patent
Implementing a Value-Driven Portfolio Process
Biologics vs Small Molecules
Advantages of Registering a Trademark
The Advantage of Filing First
Factors That Make a Patent Valuable
Prior Art in Prosecution vs Prior Art in Litigation
Patent Profile Analytics and Engineers
Patent Profile Analytics and Managers
Impact of Post-Grant Proceedings
Intent of Patent Laws
Limiting Issues Defined in District Court
Contractual Intellectual Property Rights
What is an Invention?
Patent Analytics and Competition
What is a Patent Portfolio?
Office Action
How Do Patent Portfolio Values Become Concentrated over Time?
Determining Likelihood of Confusion
Post-Litigation Challenges
Steps to Obtaining a Patent
Patents 101
What is a Trademark?
Soft Assets
Rebutting a Merely Descriptive Refusal
Types of Inventions That Are Patentable
"TM" Symbol
What Do I Give up in Getting My Patent?
Helping In-House Council
Common Reasons Trademarks Are Rejected
Wasting Money on Low-Value Patents
Inter Partes Review
Risk Profile
Unanticipated OSS
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Infringing on Another Patent
Scope Concepts and Headnotes
Importance of Getting a Patent
Becoming a Patent Lawyer
Goal of a Value-Driven Patent Portfolio
OSS Licensing Conditions
Trade Names vs Trademarks
Portfolio Dashboard - Inventor Information
Assessing Executive Experience
Infringement on the Rights of Other Patents
Low Risk Joint Ventures
The Case of the Joint Marketing Agreement Gone Bad
Discovering Annuity Information
Tools for Auditing a Patent Portfolio
Segmenting a Portfolio
Geographic Insight and Patent Profile Analytics
Claim Abstraction Theory
How can OSS Negatively Affect a Company?
Intellectual Property Protection
Value Management and Risk Management
Attributes of a Good Patent
Importance of Freedom To Operate
The Different Types of Marks
Considerations Before Hiring IP Council
Types of Intellectual Property Protection
Confidential Information and Business Damage
Post-Grant Proceedings
Post-Grant Options
ITU
Consequences of a Poorly Drafted Patent
NDAs and Customers
Improving Patent Portfolio Value
Broad Patent Claim
Is A United States Registered Trademark Effective in Other Countries?
Is There Still a Place for Traditional Re-Examination?
Patent Portfolio and Budgets/Spending
Inventors and Patent Analytics
Risks of OSS
Why Is Executing an NDA Not Enough?
IP Registration Density
Ideal Patent Strategy
Repeating Competitor Audits
